UD medical inventors and entrepreneurs invited to apply through July 23 The DRIVEN Accelerator Hub, of which the University of Delaware
News
The electric grid that keeps our home lights burning and our city streets from being in the shadows is about
Prelude Therapeutics Secures $60 Million and Expands Management Team to Develop Drugs Targeting Novel Molecular Mechanisms in Cancer Prelude Therapeutics,
Grants, Hard Work Put Polymer Company on the International Map On one hand, Dr. Sumedh Surwade has worked long, lonely
Delaware In A Fintech Future Join Governor Carney to hear the findings from Delaware In A Fintech Future and connect
Exhibitor Hospitality Reception June 4, 5:30 pm – 7:30 pm
AURP BIO Health Caucus Click here to see full AURP article.
Congratulations to SAS Nanotechnologies for Winning the AkzoNobel’s Start-Up Challenge Click here to read the full article
QPS Expands Translational Medicine Unit Three-Fold to Increase Support for Biopharmaceutical, Biotechnology and cRO Partners, Address Market Demand for Gene
Bringing Life-Saving Innovations To Market Click here to see the full UDaily article
Now headquartered on the University of Delaware’s STAR Campus, Kendal Corp., a national support organization for a network of senior
Delaware Technology Park An entrepreneurial hub with a long tradition of success. People might have left their offices during the
STAR Campus may see its first residential building, with a deal with developer BPG. | DBT PHOTO BY JACOB OWENS
Cancer research firm Prelude Therapeutics recently signed a major lease to locate its future headquarters at the new Chestnut Run
As every inquisitive mind knows, the more we learn the more we realize how much we do not know. Sometimes we